Genome Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.49 M
as on 16-11-2024
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.07 M
as on 16-11-2024
- Revenue -9.16%
(FY 2023)
- Profit 42.74%
(FY 2023)
- Ebitda 84.31%
(FY 2023)
- Net Worth -20.81%
(FY 2023)
- Total Assets -14.68%
(FY 2023)
About Genome Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.49 M.
The company currently has active open charges totaling ₹7.07 M.
Aakanksha Singhal and Anita Singhal serve as directors at the Company.
- CIN/LLPIN
U24239DL2003PTC123068
- Company No.
123068
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Nov 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Genome Diagnostics Private Limited offer?
Genome Diagnostics Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Rapid Test Kit, Flavours & Aromatics, Food Enzymes, Chemical Reagents & Catalysts, Chemical Test Kits, Corona Test Kit.
Who are the key members and board of directors at Genome Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aakanksha Singhal  | Director | 19-May-2014 | Current |
| Anita Singhal | Director | 12-May-2018 | Current |
Financial Performance of Genome Diagnostics.
Genome Diagnostics Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.16% decrease. The company also saw a substantial improvement in profitability, with a 42.74% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genome Diagnostics?
In 2023, Genome Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Real Time Instrumentation Private LimitedActive 21 years 3 monthsAakanksha Singhal and Anita Singhal are mutual person
Professional Biotech Private LimitedActive 28 years 7 monthsAakanksha Singhal and Anita Singhal are mutual person
Sequence Referral Laboratories Private LimitedActive 14 years 4 monthsAakanksha Singhal and Anita Singhal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Dec 2021 | ₹1.07 M | Open |
Others Creation Date: 23 Jan 2006 | ₹6.00 M | Open |
How Many Employees Work at Genome Diagnostics?
Unlock and access historical data on people associated with Genome Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genome Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genome Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
